1. The way forward to treatment optimisation in multiple sclerosis

   OriginalPaper Pages: vI - vI

2. Preface

   • Augusto Odone

   PREFACE Pages: v1 - v1

3. Introduction

   • David Bates
   • Giancarlo Comi

   INTRODUCTION Pages: v2 - v2

4. Disease-modifying therapy in MS: a critical review of the literature

   • Douglas S. Goodin

   OriginalPaper Pages: v3 - v11

5. What do we know about the mechanism of action of disease-modifying treatments in MS?

   • Hans-Peter Hartung
   • Amit Bar-Or
   • Yannis Zoukos

   OriginalPaper Pages: v12 - v29

6. Optimising MS disease-modifying therapies: antibodies in perspective

   • Gavin Giovannoni

   OriginalPaper Pages: v30 - v35

7. MRI: role in optimising treatment

   • Anthony Traboulsee

   OriginalPaper Pages: v36 - v41

8. Importance of benefit-to-risk assessment for disease-modifying drugs used to treat MS

   • Gordon S. Francis

   OriginalPaper Pages: v42 - v49

9. Disease-modifying therapy in MS: a critical review of the literature

   • Douglas S. Goodin

   OriginalPaper Pages: v50 - v56

10. Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

    • Ludwig Kappos
    • Jens Kuhle
    • Ernst-Wilhelm Radue

    OriginalPaper Pages: v57 - v64

11. Predicting the course of relapsing-remitting MS using longitudinal disability curves

    • Anat Achiron

    OriginalPaper Pages: v65 - v68

12. Improving MS patient care

    • Peter Rieckmann

    OriginalPaper Pages: v69 - v73

13. MS patient management: the Analog Model

    • Mohammad K. Sharief

    OriginalPaper Pages: v74 - v78

14. Can databasing optimise patient care?

    • Maria Trojano

    OriginalPaper Pages: v79 - v82

15. Interactive keypad sessions: results

    OriginalPaper Pages: v83 - v87

16. Treatment optimisation in MS: progress to date and goals for the future

    • David Bates

    OriginalPaper Pages: v88 - v89